Skip to main content
. 2020 Jun 13;86(9):1753–1768. doi: 10.1111/bcp.14355

FIGURE 4.

FIGURE 4

Current biomarkers under investigation for IO agents. Longitudinal analyses of serial blood, tumour and microbiome samples may provide further insight into tumour dynamics under the treatment selection pressure of immunotherapy